This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Cameron Martino: Inventor of a Glycosidase-Based Antiviral Approach.
Introduction
Cameron Martino is an inventor associated with the University of California in La Jolla, California. His work includes a patent application exploring how enzymes that act on glycans may help diagnose, prevent, or treat viral infections.
Latest Patents
Martino is associated with 1 patent. His patent application, “Application of Microbial Glycosidase as an Anti-Viral Therapeutic, Prognostic, and Diagnostic,” describes methods and compositions for diagnosing, preventing, or treating viral infection. The proposed approach involves administering a glycosidase or sulfatase to degrade a glycan, such as heparan sulfate, with the aim of inhibiting infection, including COVID-19. The application also describes methods for identifying enzymes or microbes associated with increased susceptibility to viral infection.
Career Highlights
Martino’s listed patent work focuses on the potential use of microbial enzymes in antiviral applications. The described methods connect glycan degradation with both infection control and the identification of factors that may influence susceptibility to viral infection.
Collaborations
Martino’s listed coworker is Benjamin Kellman. The patent application reflects work associated with the University of California.
Conclusion
Cameron Martino’s patent application presents an enzyme-based approach to viral diagnosis and treatment, highlighting the potential role of glycan degradation in antiviral research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile